zidovudine has been researched along with Breast Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (45.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griesgraber, GW; Iyer, VV; McIntee, EJ; Radmer, MR; Wagner, CR | 1 |
| Celewicz, L; Czarnecka, A; Hoffmann, M; Hładoń, B; Jóźwiak, A; Laskowska, H; Olejnik, A; Ruszkowski, P | 1 |
| Bang, JK; Chirumarry, S; Gunasekaran, P; Han, J; Kim, EY; Lee, YH; Ryu, EK; Shin, SY; Soung, NK | 1 |
| Hassanpour, A; Irandoust, M; Soleimani, E; Zhaleh, H | 1 |
| Armando, RG; Gomez, DE; Gomez, DM | 1 |
| Einarsson, R; Eriksson, S; Grassi, J; Lindh, M; Ohrvik, A | 1 |
| An, SW; Chung, HC; Jeung, HC; Ji, HJ; Rha, SY; Yang, SH | 1 |
| Han, HY; Kohli, E; Vinogradov, SV; Zeman, AD | 1 |
| Günzburg, WH; Indik, S; Kulich, P; Rouault, F; Salmons, B | 1 |
| Chandrasekaran, B; Duch, DS; Kute, TE | 1 |
| Berger, A; Wallenstein, S | 1 |
| Abul-Hajj, YJ; Akanni, AO; Ballato, G; Chang, S; Larson, RS; McIntee, EJ; Wagner, CR | 1 |
| Lindsey, JC; Ryan, LM | 1 |
| Holland, JF; Melana, SM; Pogo, BG | 1 |
| Furlong, C; Multani, AS; Pathak, S | 1 |
| Gomez, DE; Olivero, OA | 1 |
| Finkelstein, DM; Goggins, WB; Schoenfeld, DA; Zaslavsky, AM | 1 |
| Farrington, CP | 1 |
| Mediavilla, MD; Sánchez-Barceló, EJ | 1 |
| Kodish, E; Lantos, JD; Siegler, M | 1 |
2 review(s) available for zidovudine and Breast Neoplasms
| Article | Year |
|---|---|
Tutorial in biostatistics methods for interval-censored data.
Topics: Acquired Immunodeficiency Syndrome; Algorithms; Breast Neoplasms; Female; Humans; Logistic Models; Statistics, Nonparametric; Survival Analysis; Time Factors; Zidovudine | 1998 |
Ethical considerations in randomized controlled clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Breast Neoplasms; Ethics Committees, Research; Ethics, Medical; Humans; Informed Consent; Mastectomy, Segmental; Patient Advocacy; Patient Selection; Personal Autonomy; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Research Design; Research Subjects; Risk Assessment; Therapeutic Human Experimentation; Zidovudine | 1990 |
18 other study(ies) available for zidovudine and Breast Neoplasms
| Article | Year |
|---|---|
Synthesis, in vitro anti-breast cancer activity, and intracellular decomposition of amino acid methyl ester and alkyl amide phosphoramidate monoesters of 3'-azido-3'-deoxythymidine (AZT).
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Screening Assays, Antitumor; Esters; Female; Humans; Tumor Cells, Cultured; Zidovudine | 2000 |
Synthesis and anticancer activity of 5'-chloromethylphosphonates of 3'-azido-3'-deoxythymidine (AZT).
Topics: Antineoplastic Agents; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Mouth Neoplasms; Organophosphonates; Prodrugs; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Zidovudine | 2011 |
Antibacterial AZT derivative regulates metastasis of breast cancer cells.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured; Wound Healing; Zidovudine | 2020 |
Increasing the anticancer activity of azidothymidine toward the breast cancer via rational design of magnetic drug carrier based on molecular imprinting technology.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Carriers; Female; Humans; Magnetite Nanoparticles; MCF-7 Cells; Molecular Imprinting; Zidovudine | 2019 |
AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model.
Topics: Actin Cytoskeleton; Adenocarcinoma; Animals; Apoptosis; beta Catenin; Breast Neoplasms; Cell Division; Cell Movement; Cell Proliferation; Cyclin D1; Disease Models, Animal; Female; Humans; Proto-Oncogene Proteins c-myc; Telomerase; Telomere Homeostasis; Wnt Signaling Pathway; Zidovudine | 2016 |
Sensitive nonradiometric method for determining thymidine kinase 1 activity.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dideoxynucleotides; Female; HeLa Cells; Hematologic Neoplasms; Humans; Immunoenzyme Techniques; Prohibitins; Regression Analysis; Reproducibility of Results; Thymidine Kinase; Thymine Nucleotides; Zidovudine | 2004 |
Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Topics: Apoptosis; Breast Neoplasms; Cellular Senescence; DNA-Binding Proteins; Dose-Response Relationship, Drug; Gene Expression; Humans; Reverse Transcriptase Inhibitors; Telomerase; Telomere; Transcription Factors; Tumor Cells, Cultured; Zidovudine | 2005 |
Formulations of biodegradable Nanogel carriers with 5'-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity.
Topics: Adenosine Triphosphate; Animals; Antiviral Agents; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Survival; Dideoxynucleotides; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Female; Fluorescent Dyes; Formazans; Humans; Influenza A virus; Inhibitory Concentration 50; Kidney; L-Lactate Dehydrogenase; Luminescent Measurements; Membrane Potentials; Mitochondria; Nanogels; Nanotechnology; Polyethylene Glycols; Polyethyleneimine; Rhodamines; Ribavirin; Sensitivity and Specificity; Tetrazolium Salts; Thymine Nucleotides; Zidovudine | 2007 |
Rapid spread of mouse mammary tumor virus in cultured human breast cells.
Topics: Animals; Breast Neoplasms; Cell Line; DNA, Viral; Humans; Mammary Tumor Virus, Mouse; Polymerase Chain Reaction; Tumor Virus Infections; Virus Replication; Zidovudine | 2007 |
Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Cell Survival; Colonic Neoplasms; Computer Simulation; DNA, Neoplasm; Drug Synergism; Flow Cytometry; Fluorouracil; Humans; Leukemia; Melanoma; Methotrexate; Pancreatic Neoplasms; S Phase; Tumor Cells, Cultured; Zidovudine | 1995 |
Weighted logrank tests to detect a transient improvement in survivorship.
Topics: Acquired Immunodeficiency Syndrome; Biometry; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Linear Models; Mass Screening; Survival Analysis; Zidovudine | 1997 |
Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Female; Floxuridine; Humans; Leukemia, T-Cell; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; RNA-Directed DNA Polymerase; Tumor Cells, Cultured; Zidovudine | 1997 |
Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.
Topics: Antimetabolites, Antineoplastic; Breast; Breast Neoplasms; Cell Division; Cell Line; Cell Survival; Clone Cells; Female; Humans; Telomerase; Tumor Cells, Cultured; Zidovudine | 1998 |
Reduction of telomeric signals in murine melanoma and human breast cancer cell lines treated with 3'-azido-2'-3'-dideoxythymidine.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; DNA, Neoplasm; Enzyme Inhibitors; Humans; In Situ Hybridization, Fluorescence; Interphase; Melanoma; Metaphase; Mice; Telomerase; Telomere; Tumor Cells, Cultured; Zidovudine | 1998 |
Correspondence re: S. M. Melana et al., Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin. Cancer Res., 4: 693-696, 1998.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Division; CHO Cells; Cricetinae; Enzyme Inhibitors; Female; Humans; Telomerase; Zidovudine | 1998 |
A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.
Topics: Acquired Immunodeficiency Syndrome; Algorithms; Analysis of Variance; Anti-HIV Agents; Biometry; Breast Neoplasms; Computer Simulation; Drug Resistance, Microbial; Female; Hemophilia A; HIV Infections; Humans; Likelihood Functions; Markov Chains; Monte Carlo Method; Proportional Hazards Models; Transfusion Reaction; Zidovudine | 1998 |
Residuals for proportional hazards models with interval-censored survival data.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biometry; Breast Neoplasms; CD4 Lymphocyte Count; Female; Humans; Models, Statistical; Proportional Hazards Models; Regression Analysis; Survival Analysis; Time Factors; Zidovudine | 2000 |
Doses and time-dependent effects of 3'-azido-3'-deoxythymidine on T47D human breast cancer cells in vitro.
Topics: Analysis of Variance; Antimetabolites; Apoptosis; Breast Neoplasms; Cell Cycle; Dose-Response Relationship, Drug; Drug Administration Schedule; Flow Cytometry; Humans; Tumor Cells, Cultured; Zidovudine | 2000 |